<p><h1>Measles Vaccine Market Research Report Reveals The Latest Trends And Opportunities of this Market for Period from 2024 - 2031</h1></p><p><strong>Measles Vaccine Market Analysis and Latest Trends</strong></p>
<p><p>Measles vaccine is a vaccine that prevents measles, a highly contagious viral infection that can result in serious complications such as pneumonia, encephalitis, and even death. The vaccine is typically administered in combination with vaccines for mumps and rubella as part of the MMR vaccine.</p><p>The global measles vaccine market is expected to experience steady growth during the forecast period, with a projected CAGR of 4.50%. The increasing prevalence of measles outbreaks in various regions, along with government initiatives to promote vaccination programs, are driving the growth of the market. Additionally, advancements in vaccine technology and increasing awareness about the importance of immunization are further fueling market growth.</p><p>One of the key trends in the measles vaccine market is the introduction of new combination vaccines that offer protection against multiple diseases in a single shot. This not only increases convenience for patients but also helps in improving vaccination coverage rates. Moreover, ongoing research and development activities aimed at developing more effective and safer vaccines are expected to further drive market growth in the coming years.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reportprime.com/enquiry/request-sample/16170">https://www.reportprime.com/enquiry/request-sample/16170</a></p>
<p>&nbsp;</p>
<p><strong>Measles Vaccine Major Market Players</strong></p>
<p><p>The Measles Vaccine Market is highly competitive and dominated by major players such as GSK, Sanofi Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic, Emergent Biosolutions, Medimmune, Johnson & Johnson, and CSL Limited. </p><p>Among these companies, GSK, Sanofi Pasteur, and Merck are the leading players in the measles vaccine market. GSK has a significant market share with its measles-containing vaccines, M-M-R II and Priorix. Sanofi Pasteur's measles vaccines, M-M-R II and RORVax, are also widely used globally. Merck's measles vaccine, Mumpsvax, is another key product in the market.</p><p>In terms of market growth, companies like Pfizer, Serum Institute of India, and Novartis are also expanding their presence in the measles vaccine market. These companies are investing in research and development to develop new and improved measles vaccines. Serum Institute of India, for example, has been increasing its production capacity to meet the growing demand for measles vaccines in emerging markets.</p><p>The global measles vaccine market size is projected to reach $6.2 billion by 2025, with a CAGR of 5.3% from 2020 to 2025. GSK, Sanofi Pasteur, and Merck are expected to continue dominating the market during this period.</p><p>In terms of sales revenue, GSK reported sales of approximately $9.1 billion in 2019, while Sanofi Pasteur's vaccine division reported sales of approximately $5.7 billion in the same year. Merck's vaccine sales were around $9.8 billion in 2019, making it one of the leading vaccine manufacturers globally. These figures highlight the strong market position and growth potential of these companies in the measles vaccine market.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Measles Vaccine Manufacturers?</strong></p>
<p><p>The global measles vaccine market is expected to experience significant growth in the coming years, driven by increasing awareness about the importance of immunization and the expansion of vaccination programs in developing countries. Technological advancements in vaccine development and distribution are also contributing to the market growth. Additionally, the ongoing efforts by healthcare organizations and governments to eradicate measles are expected to further boost market revenue. The future outlook for the measles vaccine market is positive, with a steady increase in demand for effective vaccination against this highly contagious disease.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reportprime.com/enquiry/pre-order/16170">https://www.reportprime.com/enquiry/pre-order/16170</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Measles Vaccine Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Mumps Measles Rubella Vaccine, Live (MMR-II)</li><li>Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)</li></ul></p>
<p><p>The Measles Vaccine Market includes various types of vaccines, such as the Mumps Measles Rubella Vaccine, Live (MMR-II) and the Mumps Measles Rubella and Varicella Virus Vaccine (Proquad). These vaccines are used to prevent measles, mumps, rubella, and varicella (chickenpox). MMR-II is a combination vaccine that protects against all three diseases, while Proquad also includes protection against varicella. These vaccines are essential tools in preventing the spread of these highly contagious diseases and are widely used in immunization programs worldwide.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reportprime.com/checkout?id=16170&price=3590">https://www.reportprime.com/checkout?id=16170&price=3590</a></p>
<p>&nbsp;</p>
<p><strong>The Measles Vaccine Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Children</li><li>Adults</li></ul></p>
<p><p>The measles vaccine is widely used in both children and adults to prevent the spread of measles, a highly contagious viral infection. In the children's market, the vaccine is administered as part of routine immunization schedules to protect them from developing measles and its complications. In the adult market, the vaccine is recommended for those who have not been previously vaccinated or are at risk of exposure to the virus. Overall, the measles vaccine application aims to reduce the incidence of measles and its associated health risks in both populations.</p></p>
<p><a href="https://www.reportprime.com/measles-vaccine-r16170">&nbsp;https://www.reportprime.com/measles-vaccine-r16170</a></p>
<p><strong>In terms of Region, the Measles Vaccine Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The measles vaccine market is anticipated to witness significant growth in North America (NA), Asia Pacific (APAC), Europe, USA, and China due to increasing awareness about the benefits of vaccination and government initiatives to control measles outbreaks. The regions expected to dominate the market are North America with a market share of 35%, followed by Europe with 25%, Asia Pacific with 20%, USA with 15%, and China with 5%. This indicates a promising outlook for the measles vaccine market in the coming years.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reportprime.com/checkout?id=16170&price=3590">https://www.reportprime.com/checkout?id=16170&price=3590</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reportprime.com/enquiry/request-sample/16170">https://www.reportprime.com/enquiry/request-sample/16170</a></p>
<p><strong></strong></p>
<p><p><a href="https://www.linkedin.com/pulse/medical-grade-cobalt-60-market-size-examines-its-scope-primary-qlgnc?trackingId=WchoUE%2BLt6NfvfOJvyQRWg%3D%3D">Medical-grade Cobalt-60 Market</a></p><p><a href="https://www.linkedin.com/pulse/hafnium-hf-evaporation-materials-market-analysis-examines-fsohc?trackingId=e6v8Y4ylSeWROIlSWCjRpQ%3D%3D">Hafnium (Hf) Evaporation Materials Market</a></p><p><a href="https://www.linkedin.com/pulse/cobalt-60-source-market-offers-provide-insightful-data-h2ozc?trackingId=Hwfztl1F1J5vw33P6l%2Bzjw%3D%3D">Cobalt-60 Source Market</a></p></p>